Transcripts of testicular gonadotropin-releasing hormone, steroidogenic enzymes, and intratesticular testosterone levels in infertile men  Yung Ming Lin,

Slides:



Advertisements
Similar presentations
J.C. Trussell, M.D., Allen R. Kunselman, M.A., Richard S. Legro, M.D. 
Advertisements

Male infertility: a biomarker of individual and familial cancer risk
Testicular expression of synaptonemal complex protein 3 (SYCP3) messenger ribonucleic acid in 110 patients with nonobstructive azoospermia  Mahmoud Aarabi,
Le-Jun Li, M. D. , Feng-Bin Zhang, M. D. , Shu-Yuan Liu, M. D
Male contraception Fertility and Sterility
Ratio between inner cell mass diameter and blastocyst diameter is correlated with successful pregnancy outcomes of single blastocyst transfers  Miriam.
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor.
Won Heum Nah, M. Sc. , Jae Eun Lee, M. Sc. , Hyun Jun Park, M. D. , Ph
Michael M. Alper, M.D.  Fertility and Sterility 
Apoptosis-inhibitor Aven is downregulated in defective spermatogenesis and a novel estrogen target gene in mammalian testis  Sandra Laurentino, B.Sc.,
Ming-hui Chen, M. D. , Tao Li, Ph. D. , Chen-hui Ding, Ph. D
Hepatitis and reproduction
Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist.
Phenotypic characterization of the immune and mast cell infiltrates in the human testis shows normal and abnormal spermatogenesis  Mahmoud R. Hussein,
Boback M. Berookhim, M. D. , M. B. A. , Gianpiero D. Palermo, M. D
Temporal trends in clomiphene citrate use: a population-based study
Medical treatment of ectopic pregnancy: a committee opinion
Testosterone use in the male infertility population: prescribing patterns and effects on semen and hormonal parameters  Mary K. Samplaski, M.D., Yasir.
Clomiphene citrate potentiates the adverse effects of estrogen on rat testis and down- regulates the expression of steroidogenic enzyme genes  Shilpa Bharti,
Gene-based screening for Y chromosome deletions in Taiwanese men presenting with spermatogenic failure  Yung-Ming Lin, M.D., Ying-Hung Lin, M.Sc., Yen-Ni.
Potential diagnostic utility of intermittent administration of short-acting gonadotropin- releasing hormone agonist in gonadotropin deficiency  Carrie.
Transurethral partial cystectomy and laparoscopic reconstruction for the management of bladder endometriosis  See-Tong Pang, M.D., Ph.D., Angel Chao,
MicroRNA expression profiles in human testicular tissues of infertile men with different histopathologic patterns  Masood Abu-Halima, M.Sc., Christina.
Association of a single dose of gonadotropin-releasing hormone antagonist with nitric oxide and embryo quality in in vitro fertilization cycles  Tsung-Hsien.
Mithra L. Narasimhan, M.B.B.S., Ahmed Khattab, M.D. 
Ramadan Saleh, M. D. , Reda Z. Mahfouz, M. D. , Ashok Agarwal, Ph. D
Reply of the Authors Fertility and Sterility
Robert F. Casper, M.D.  Fertility and Sterility 
Heat shock factor Y chromosome (HSFY) mRNA level predicts the presence of retrievable testicular sperm in men with nonobstructive azoospermia  Peter J.
Ultrashort flare gonadotropin-releasing hormone (GnRH) agonist/GnRH antagonist protocol: a valuable tool in the armamentarium of ovulation induction for.
Involvement of the Fas–Fas ligand system and active caspase-3 in abnormal apoptosis in human testes with maturation arrest and Sertoli cell–only syndrome 
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Male infertility: a biomarker of individual and familial cancer risk
Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated.
Weon-Young Son, Ching-Tack Han, Ph. D
Treatment of Ovarian Hyperstimulation Syndrome Utilizing a Dopamine Agonist and Gonadotropin Releasing Hormone antagonist  N. Rollene, M. Amols, S. Hudson,
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction–intrauterine insemination to in vitro.
Evaluation of diagnostic testis biopsy and the repetition of testicular sperm extraction surgeries in infertility patients  Alayman Hussein, M.B.B.C.H.,
Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage,
Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting  Basil Ho Yuen, M.B., Ch.B., Tuan-Anh.
Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol  Georg Griesinger, M.D., Anja Dawson, M.D., Askan Schultze-Mosgau,
David E. Reichman, M. D. , Stacey A. Missmer, Sc. D. , Katharine F
Serum inhibin B and anti-Müllerian hormone are not superior to follicle-stimulating hormone as predictors of the presence of sperm in testicular fine-needle.
Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D
Altered expression pattern of heat shock transcription factor, Y chromosome (HSFY) may be related to altered differentiation of spermatogenic cells in.
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Identification of ten novel genes involved in human spermatogenesis by microarray analysis of testicular tissue  Ying-Hung Lin, M.Sc., Yung-Ming Lin,
Effect of gonadotropin-releasing-hormone-induced hypogonadism on insulin action as assessed by euglycemic clamp studies in men  Subodhsingh Chauhan, M.D.,
The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is.
Fertility and Sterility: an evaluation
Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of.
Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin- releasing hormone agonist short regimen on alternate days and an antagonist.
Yen-Ni Teng, Ph. D. , Yung-Ming Lin, M. D. , Hsiao-Fang Sunny Sun, Ph
Giovanna Mantovani, M. D. , Mario Mancini, M. D. , Giacomo Gazzano, M
Current evaluation of amenorrhea
A simplified novel laparoscopic formation of neovagina for cases of Mayer-Rokitansky- Küster-Hauser syndrome  Atef Mohammad Darwish, M.D.  Fertility and.
Inappropriate gonadotropin secretion in polycystic ovary syndrome
Variability in testis biopsy interpretation: implications for male infertility care in the era of intracytoplasmic sperm injection  Matthew R. Cooperberg,
A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human.
Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists 
The gonadotropin-releasing hormone (GnRH)-1 gene, the GnRH receptor gene, and their promoters in patients with idiopathic hypogonadotropic hypogonadism.
Saad Elzanaty, M.D., Ph.D., Johan Malm, M.D., Ph.D. 
CAG repeat length variation in the Androgen Receptor gene is not associated with spermatogenic failure  Henrike Westerveld, M.D., Liesbeth Visser, M.Sc.,
Expression pattern of germ cell–specific genes in the testis of patients with nonobstructive azoospermia: usefulness as a molecular marker to predict.
Tomomoto Ishikawa, M. D. , Ph. D. , Yutaka Kondo, M. D
Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing.
In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation 
P-24 Fertility and Sterility Volume 85, Pages S19-S20 (April 2006)
Presentation transcript:

Transcripts of testicular gonadotropin-releasing hormone, steroidogenic enzymes, and intratesticular testosterone levels in infertile men  Yung Ming Lin, M.D., Song Ling Poon, M.Sc., Jung Hye Choi, Ph.D., Johnny Shinn Nan Lin, M.D., Peter C.K. Leung, Ph.D., Bu Miin Huang, Ph.D.  Fertility and Sterility  Volume 90, Issue 5, Pages 1761-1768 (November 2008) DOI: 10.1016/j.fertnstert.2007.08.078 Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Messenger RNA transcript levels of GnRH-I (A), GnRH-II (B), and GnRH-R (C) and the GnRH-I/GnRH-II ratio (D) in different testicular histopathological groups. Significant differences were found among the four groups for GnRH-I (P=.001), GnRH-II (P=.01), and GnRH-R (P=.01). Asterisks indicate statistical difference between the normal spermatogenesis and spermatogenic failure groups (∗P<.05; ∗∗P<.01). NR = normal spermatogenesis; HS = hypospermatogenesis; MA = maturation arrest; SCOS = Sertoli cell–only syndrome. Fertility and Sterility 2008 90, 1761-1768DOI: (10.1016/j.fertnstert.2007.08.078) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Correlations between GnRH transcripts and GnRH-R transcripts. Positive and significant correlations were noted between GnRH-I (A) and -II (B) transcripts and GnRH-R transcripts. The r-value and significance value (P) are shown on each graph. NR = normal spermatogenesis; HS = hypospermatogenesis; MA = maturation arrest; SCOS = Sertoli cell–only syndrome. Fertility and Sterility 2008 90, 1761-1768DOI: (10.1016/j.fertnstert.2007.08.078) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Messenger RNA transcript levels of steroidogenic enzymes in different testicular histopathological groups. No significant difference were found among the four groups for StAR (A), CYP17A1 (B), and HSD17B3 (C) (P=.123, .067, and .215, respectively). Significant differences were found among the four groups for the CYP11A1 (D) and HSD3B2 (E) genes (P=.039 and .002, respectively). Asterisks indicate statistical difference between the normal spermatogenesis and spermatogenic failure groups (∗P<.05; ∗∗P<.01). NR = normal spermatogenesis; HS = hypospermatogenesis; MA = maturation arrest; SCOS = Sertoli cell–only syndrome. Fertility and Sterility 2008 90, 1761-1768DOI: (10.1016/j.fertnstert.2007.08.078) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions